Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Facial Palsy Treatment: Investigating the Most Effective Modality of Therapy for Recovery?

NCT06976814 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT06976814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06976814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Facial Palsy Treatment: Investigating the Most Effective Modality of Therapy for Recovery?
Lead sponsor
Hamad Medical Corporation
Phase
Not applicable
Overall status
Completed
Start date
April 19, 2021
Completion date
June 29, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

facial palsy, stroke rehabilitation